Tech Company Financing Transactions
Armune BioScience Funding Round
Private investors participated in a $5.6 million funding round for Armune BioScience. The round closed on 2/19/2016.
Transaction Overview
Company Name
Announced On
2/19/2016
Transaction Type
Venture Equity
Amount
$5,552,032
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
350 East Michigan Ave. 500
Kalamazoo, MI 49007
USA
Kalamazoo, MI 49007
USA
Phone
Website
Email Address
Not Recorded
Overview
New tests to aid in risk assessment for lung, breast, and prostate cancers using biomarkers produced in response to the onset of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Donald Parfet
Chief Executive Officer
David Esposito
Chief Financial Officer
Susan Crookston
Chief Medical Officer
Robert Reinhardt
Chief Operating Officer
James Arthurs
Chief Scientific Officer
Sharat Singh
Browse more venture capital transactions:
Prev: 2/18/2016: Chronogolf venture capital transaction
Next: 2/19/2016: Pliant Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs